CALT - Calliditas Therapeutics AB (CALT) CEO Renée Lucander on Q1 2021 Results - Earnings Call Transcript
Calliditas Therapeutics AB (CALT) Q1 2021 Earnings Conference Call May 18, 2021 08:30 AM ET Company Participants Renée Lucander - CEO Richard Philipson - Chief Medical Officer Fredrik Johansson - CFO Andrew Udell - President, North America Conference Call Participants Yigal Nochomovitz - Citigroup Maury Raycroft - Jefferies Edwin Zhang - H.C. Wainwright Nicholas Rubino - Stifel Rami Katkhuda - LifeSci Capital Presentation Operator Ladies and gentlemen, welcome to the Calliditas Therapeutics Q1 2021 Conference. [Operator Instructions] I'll now hand the floor to CEO, Renee Lucander. Please begin your meeting. Renée Lucander Thank you, and welcome to this Q1 2021 report from Calliditas. If you turn to Page 2, and before we begin, giving our listing on NASDAQ Global Select, I would just like to draw your attention to the forward-looking statements. So turning to Page 3. In Q1, the company reached a major milestone with a filing for approval
For further details see:
Calliditas Therapeutics AB (CALT) CEO Renée Lucander on Q1 2021 Results - Earnings Call Transcript